Optimal deep brain stimulation site and target connectivity for chronic cluster headache

Harith Akram, Sarah Miller, Susie Lagrata, Marwan Hariz, John Ashburner, Timothy E.j. Behrens, Manjit Matharu, Ludvic ZrinzoNeurology 2017 · DOI

TL;DR

This study pinpoints the optimal location and brain connectivity for deep brain stimulation (DBS) in treating chronic cluster headaches (CCH). By combining advanced MRI techniques with patient outcome data, researchers identified a specific area within the ventral tegmental area (VTA) and its connections to the trigeminal system and hypothalamus as crucial for therapeutic efficacy.

What Problem Does This Paper Address?

Chronic cluster headache (CCH) is a debilitating neurological disorder characterized by excruciating, unilateral head pain accompanied by autonomic symptoms. While deep brain stimulation (DBS) has shown promise as a treatment for refractory CCH, its precise mechanism of action and the optimal target location within the brain have remained unclear. Previous studies have implicated the hypothalamus, but the exact stimulation site and the neural pathways involved in pain modulation for CCH are not well-defined. This paper aims to address this gap by identifying the most effective DBS target site and understanding its structural connectivity to elucidate potential therapeutic mechanisms.

Methods

The researchers employed a multi-faceted approach combining advanced neuroimaging and clinical outcome analysis:

  • High-Resolution Diffusion MRI: Preoperative diffusion-weighted MRI was used to map the white matter tracts in seven CCH patients.
  • MRI-Guided Electrode Implantation: DBS electrodes were implanted unilaterally or bilaterally in the ventral tegmental area (VTA) under MRI guidance.
  • Volume of Tissue Activation (VTA) Modeling: Finite-element models were used to generate VTA around the active DBS contacts, estimating the area of brain tissue influenced by stimulation.
  • Voxel-Based Morphometry (VBM) Regression Analysis: This technique was used to correlate the VTA with patient-reported reductions in headache load (HAL). This allowed them to identify voxels associated with higher treatment efficacy.
  • Probabilistic Tractography: This method was used to map the brain connectivity of the VTA in patients who responded to treatment. By seeding the tractography from the active DBS contacts, they could identify the neural pathways connected to the stimulation site.
  • Standardized Outcome Measures: Patients were assessed using headache diaries to track headache load, attack severity, frequency, and duration over a 12-month follow-up period. Responders were defined as those achieving a ≥30% reduction in HAL.

Datasets

The study utilized data from seven patients diagnosed with medically refractory chronic cluster headache. These patients underwent preoperative MRI scans and subsequent DBS implantation. The primary dataset consisted of the MRI data (diffusion-weighted and MPRAGE images) and the clinical outcome data collected over a mean follow-up of 34 months. No new public datasets were introduced.

Key Insights and Ideas

  • Optimal VTA Target Identified: The study pinpointed a specific region within the VTA, located approximately 6 mm lateral, 2 mm posterior, and 1 mm inferior to the midcommissural point (MCP), as the most effective stimulation site for reducing headache load in CCH patients.
  • Trigeminohypothalamic Tract (THT) Connectivity is Key: Responders' VTA consistently overlapped with the THT, a pathway connecting the trigeminal system (involved in head pain) with the hypothalamus (a key regulator of autonomic functions and pain modulation). This suggests that modulating this tract is central to DBS efficacy in CCH.
  • Dual Pathway Modulation: The THT appears to connect the VTA not only to the hypothalamus but also to other brainstem nuclei involved in pain processing and to higher-level areas like the prefrontal cortex and mesial temporal lobe. This indicates a complex, top-down modulation of pain pathways.
  • Non-Responder VTA Outside Efficacy Cluster: The single non-responder's VTA was located outside the identified high-efficacy cluster, further supporting the specificity of the optimal target.
  • Potential for Top-Down Antinociception: The identified connectivity suggests that DBS in this VTA region may exert a top-down antinociceptive effect, dampening pain signals before they reach higher brain centers.

Key Results

  • Significant Headache Reduction: Six out of seven patients responded to DBS, showing significant reductions in headache load (76% ± 33%), attack severity (46% ± 41%), frequency (58% ± 41%), and duration (51% ± 46%) at the last follow-up.
  • Efficacy Cluster Location: The statistically significant cluster predictive of improvement in HAL was located in the superior, posterior, and lateral portion of the group average activation volume.
  • Tractography Findings: Probabilistic tractography revealed that the VTA in responders connected anteriorly to the hypothalamus, mesial temporal lobe, and prefrontal areas, and posteriorly to the periaqueductal gray and the trigeminal nucleus and tract.
  • No Surgical Morbidity: The study reported no surgical complications or mortality. Minor transient adverse events were reported but resolved with stimulation adjustments.

Limitations and Future Work

  • Small Sample Size: The study included only seven patients, with only one non-responder. This limits the ability to perform robust group comparisons between responders and non-responders to definitively identify negative outcome predictors.
  • Difficulty in Precise Target Localization: The authors acknowledge the inherent challenges in precisely localizing DBS targets due to the relatively large VTA and the limitations of current imaging techniques.
  • Mechanism of Action Still Under Investigation: While the study identifies crucial connectivity, the exact cellular and molecular mechanisms by which VTA stimulation modulates CCH remain to be fully elucidated.
  • Future Directions: The authors suggest that future research could explore the role of specific neurotransmitters and pathways in more detail. Further studies with larger cohorts are needed to confirm the optimal target and to investigate the potential for differentiating pathways involved in pain versus autonomic symptoms of CCH. The study also highlights the need for more precise methods for localizing DBS targets.

Summary updated

Abstract

We identify the optimal stimulation site and structural connectivity of the deep brain stimulation target for cluster headache, explicating possible mechanisms of action and disease pathophysiology.
BibTeX
@inproceedings{akram2017optimal,
  author = {Harith Akram and Sarah Miller and Susie Lagrata and Marwan Hariz and John Ashburner and Timothy E.J. Behrens and Manjit Matharu and Ludvic Zrinzo},
  title = {{Optimal deep brain stimulation site and target connectivity for chronic cluster headache}},
  booktitle = {Neurology},
  year = {2017},
  doi = {10.1212/wnl.0000000000004646},
}
Figure